ADVOCIN INJECTABLE SOLUTION 2.5 % VETERINARY

Quốc gia: Israel

Ngôn ngữ: Tiếng Anh

Nguồn: Ministry of Health

Thành phần hoạt chất:

DANOFLOXACIN AS MESYLATE

Sẵn có từ:

ZOETIS ISRAEL HOLDING B.V., ISRAEL

Dạng dược phẩm:

SOLUTION FOR INJECTION

Thành phần:

DANOFLOXACIN AS MESYLATE 25 MG/ML

Tuyến hành chính:

I.M, S.C

Loại thuốc theo toa:

Required

Sản xuất bởi:

FAREVA AMBOISE, FRANCE

Chỉ dẫn điều trị:

For the treatment of cattle (calves, beef cattle and non-lactating dairy cattle) with respiratory infections caused by Pasteurella haemolytica and Pasteurella multocida, enteric infections caused by e.coli and salmonela spp.Only after sensitivity to danofloxacin has been confirmed by laboratory tests and after no alternative treatment was found effective (proved resistence to other treatments).

Ngày ủy quyền:

2019-01-31

Đặc tính sản phẩm

Advocin 2.5% Veterinary LPD
.2020
2
20.0
1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Advocin Injectable Solution 2.5% Veterinary
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE: Danofloxacine (as mesylate) equivalent to
danofloxacine 25.0 mg/ml
For the full list of all other excipients see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, light yellow solution
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Cattle.
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of cattle (calves, beef cattle and non-lactating
dairy
cattle) with respiratory infections caused by _Pasteurella
haemolytica_ and
_Pasteurella multocida_, enteric infections caused by _E.coli_ and
_Salmonela_
spp. Only after sensitivity to danofloxacin has been confirmed by
laboratory tests and after no alternative treatment was found
effective
(proved resistance to other treatments).
4.3.
CONTRAINDICATIONS
None
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Not applicable
4.5.
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Fluoroquinolones
should
be
reserved
for
the
treatment
of
clinical
conditions which have responded poorly, or are expected to respond
poorly, to other classes of antimicrobials.
Whenever possible, fluoroquinolones should only be used based on
susceptibility testing.
Use of the product deviating from the instructions given in the SPC
may
increase the prevalence of bacteria resistant to the fluoroquinolones
and
Advocin 2.5% Veterinary LPD
.2020
2
20.0
2
may decrease the effectiveness of treatment with other quinolones due
to the potential for cross resistance.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Wash hands after use.
4.6.
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None
Reporting suspected adverse reactions after authorization of the
medicinal product is important. It allows continued monitoring of the
benefit/risk balance of the medicinal product. Any suspected a